Daewon Pharmaceutical Develops Oral Obesity Drug Absorption Technology... "Up to 3.14 Times Better Than Rybelsus"
Predicted impact: Low
Oral obesity drug absorption tech; early research with no revenue size.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.